Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AX Other antihistamines for systemic use
R06AX26 Fexofenadine
D00671 Fexofenadine hydrochloride (JP18/USP) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
44 Allergic agents
449 Miscellaneous
4490 Miscellaneous
D00671 Fexofenadine hydrochloride (JP18/USP)
Classification of Japanese OTC drugs [BR:br08313]
Agents for otolaryngologic use
69 Oral medicine for nasal inflammation
D00671 Fexofenadine hydrochloride (JP18/USP)
Risk category of Japanese OTC drugs [BR:br08312]
First-class OTC drugs
Inorganic and organic chemicals
Fexofenadine
D00671 Fexofenadine hydrochloride (JP18/USP)
Second-class OTC drugs
Inorganic and organic chemicals
Fexofenadine
D00671 Fexofenadine hydrochloride (JP18/USP)
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
DG01117 Fexofenadine
D00671 Fexofenadine hydrochloride
Drug classes [BR:br08332]
Anti-allergic agent
DG01482 Histamine receptor H1 antagonist
D00671 Fexofenadine hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH1
D00671 Fexofenadine hydrochloride (JP18/USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00671 Fexofenadine hydrochloride
D00671 Fexofenadine hydrochloride tablets
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00671
Rx-to-OTC switch list in the USA [br08315.html]
D00671
Rx-to-OTC switch list in Japan [br08314.html]
D00671
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
DG01117 Fexofenadine
Other DBs
CAS:
153439-40-8
PubChem:
7847737
ChEBI:
5051
LigandBox:
D00671
NIKKAJI:
J871.596C
KCF data
ATOM 38
1 C8x C 4.7600 -25.5500
2 C8x C 4.7600 -26.9500
3 C8x C 5.9724 -27.6500
4 C8x C 7.1849 -26.9500
5 C8y C 7.1849 -25.5500
6 C8x C 5.9724 -24.8500
7 C8x C 9.6097 -26.9500
8 C8y C 9.6097 -25.5500
9 C1d C 8.3973 -24.8500
10 C8x C 10.8222 -27.6500
11 C8x C 12.0346 -26.9500
12 C8x C 12.0346 -25.5500
13 C8x C 10.8222 -24.8500
14 C1y C 8.3973 -23.4500
15 C1x C 9.6118 -22.7488
16 C1x C 9.6118 -21.3488
17 N1y N 8.3993 -20.6488
18 C1x C 7.1849 -21.3500
19 C1x C 7.1849 -22.7500
20 O1a O 7.1849 -24.1500
21 C1b C 8.3993 -19.2500
22 C1b C 9.6123 -18.5497
23 C1b C 10.8080 -19.2402
24 C1c C 11.9952 -18.5549
25 C8y C 13.1865 -19.2429
26 O1a O 11.9954 -17.1502
27 C8x C 13.1865 -20.6497
28 C8x C 14.3989 -21.3498
29 C8y C 15.6113 -20.6498
30 C8x C 15.6114 -19.2430
31 C8x C 14.3990 -18.5429
32 C1d C 16.8228 -21.3493
33 C6a C 18.0178 -20.6593
34 O6a O 19.2053 -21.3450
35 O6a O 18.0179 -19.2503
36 C1a C 15.8329 -22.3393
37 C1a C 17.8128 -22.3393
38 X Cl 16.5900 -25.3400
BOND 40
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 7 8 1
8 8 9 1
9 5 9 1
10 7 10 2
11 10 11 1
12 11 12 2
13 12 13 1
14 8 13 2
15 9 14 1
16 14 15 1
17 15 16 1
18 16 17 1
19 17 18 1
20 18 19 1
21 14 19 1
22 9 20 1
23 17 21 1
24 21 22 1
25 22 23 1
26 23 24 1
27 24 25 1
28 24 26 1
29 25 27 2
30 27 28 1
31 28 29 2
32 29 30 1
33 30 31 2
34 25 31 1
35 29 32 1
36 32 33 1
37 33 34 1
38 33 35 2
39 32 36 1
40 32 37 1